| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neurogene Inc. | Director | Non-Qualified Stock Option (right to buy) | 12,050 | 20 Feb 2026 | Direct | ||
| Mosaic ImmunoEngineering Inc. | Director | Convertible Note | $50,000 | 18 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NGNE | Neurogene Inc. | 20 Feb 2026 | 1 | $0 | 4 | Director | 24 Feb 2026, 18:41 |
| NGNE | Neurogene Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 12:07 |
| NGNE | Neurogene Inc. | 14 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 14:36 |
| NGNE | Neurogene Inc. | 16 Jan 2024 | 1 | $0 | 4 | Director | 18 Jan 2024, 18:51 |
| NGNE | Neurogene Inc. | 18 Dec 2023 | 0 | $0 | 3 | Director | 26 Dec 2023, 18:10 |
| CPMV | Mosaic ImmunoEngineering Inc. | 18 Feb 2022 | 1 | +$50,000 | 4 | Director | 22 Feb 2022, 18:55 |
| CPMV | Mosaic ImmunoEngineering Inc. | 15 Jul 2021 | 0 | $0 | 3 | Director | 16 Jul 2021, 18:19 |